We are live on
!
Find out more
RAM
RWC Asset Management Portfolio holdings
AUM
$2.4B
1-Year Est. Return
29.54%
This Fund
S&P 500
This Quarter
Est. Return
+1.47%
1 Year Est. Return
+29.54%
3 Year Est. Return
+59.96%
5 Year Est. Return
+73.83%
10 Year Est. Return
+397.32%
AUM
$774M
AUM Growth
–
Cap. Flow
+$320M
Cap. Flow
% of AUM
41.32%
Top 10 Holdings %
Top 10 Hldgs %
34.73%
Holding
108
New
74
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Pfizer
PFE
|
+$29.1M |
| 2 |
Merck
MRK
|
+$26.5M |
| 3 |
Eli Lilly
LLY
|
+$24.9M |
| 4 |
Johnson & Johnson
JNJ
|
+$21.3M |
| 5 |
Microsoft
MSFT
|
+$19.9M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 12.7% |
| 2 | Technology | 8.18% |
| 3 | Consumer Discretionary | 5.85% |
| 4 | Consumer Staples | 2.87% |
| 5 | Financials | 2.54% |
Similar funds
PA
DSCM
FHC
MAS
RG
CWM
HAG
VF
RWC Asset Management's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for RWC Asset Management, which disclosed 108 positions worth $774M. Its ten largest holdings account for 35% of the portfolio.
Its largest position is Pfizer: 1,053,181 shares worth $28M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, followed by Technology and Consumer Discretionary.
- RWC Asset Management's largest Q2 2013 buy was Pfizer: 1,053,181 shares worth $28M.
- RWC Asset Management's ten largest holdings make up 35% of its $774M portfolio in Q2 2013.
- RWC Asset Management disclosed 108 positions in Q2 2013, its first 13F filing on record.
Based on RWC Asset Management's 13F filing for Q2 2013, filed 5 Sep 2013.